Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001909136 | SCV002174126 | uncertain significance | Hypertrophic cardiomyopathy 14 | 2021-08-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002344000 | SCV002653677 | uncertain significance | Cardiovascular phenotype | 2023-11-29 | criteria provided, single submitter | clinical testing | The p.M1842V variant (also known as c.5524A>G), located in coding exon 34 of the MYH6 gene, results from an A to G substitution at nucleotide position 5524. The methionine at codon 1842 is replaced by valine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species, and valine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |